Preventive Vaccine Market Size, Growth, Global Trends, Forecast 2034

Preventive Vaccine Market

Preventive Vaccine Market By Vaccine Type (Inactivated Vaccines, Live/Attenuated Vaccines, Toxoid Vaccines, Subunit Vaccines, and Others), By Disease Type (Hepatitis, Poliovirus, Pneumococcal, Rubella, Measles, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034

Category: Healthcare Report Format : PDF Pages: 214 Report Code: ZMR-10140 Published Date: Dec-2025 Status : Published
Market Size in 2024 Market Forecast in 2034 CAGR (in %) Base Year
USD 59.83 Billion USD 136.46 Billion 9.12% 2024

Preventive Vaccine Market

Request Free Sample

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Preventive Vaccine Market, (2025 - 2034) (USD Billion )
    • 2.2 Global Preventive Vaccine Market : snapshot
  • Chapter 3. Global Preventive Vaccine Market - Industry Analysis
    • 3.1 Preventive Vaccine Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Growing cases of infectious diseases worldwide are expected to propel market expansion trends in the future
    • 3.3 Market Restraints
      • 3.3.1. Cost-related barriers restrict preventive vaccine market growth
    • 3.4 Market Opportunities
      • 3.4.1. Surging demand for cancer-preventing vaccines offers growth opportunities to the market players
    • 3.5 Market Challenges
      • 3.5.1. Regulatory hurdles and scaling complexities to challenge market growth trends
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Vaccine Type
      • 3.7.2 Market attractiveness analysis By Disease Type
  • Chapter 4. Global Preventive Vaccine Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Preventive Vaccine Market: company market share, 2024
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Preventive Vaccine Market - Vaccine Type Analysis
    • 5.1 Global Preventive Vaccine Market overview: By Vaccine Type
      • 5.1.1 Global Preventive Vaccine Market share, By Vaccine Type, 2024 and 2034
    • 5.2 Inactivated Vaccines
      • 5.2.1 Global Preventive Vaccine Market by Inactivated Vaccines, 2025 - 2034 (USD Billion )
    • 5.3 Live/Attenuated Vaccines
      • 5.3.1 Global Preventive Vaccine Market by Live/Attenuated Vaccines, 2025 - 2034 (USD Billion )
    • 5.4 Toxoid Vaccines
      • 5.4.1 Global Preventive Vaccine Market by Toxoid Vaccines, 2025 - 2034 (USD Billion )
    • 5.5 Subunit Vaccines
      • 5.5.1 Global Preventive Vaccine Market by Subunit Vaccines, 2025 - 2034 (USD Billion )
    • 5.6 Others
      • 5.6.1 Global Preventive Vaccine Market by Others, 2025 - 2034 (USD Billion )
  • Chapter 6. Global Preventive Vaccine Market - Disease Type Analysis
    • 6.1 Global Preventive Vaccine Market overview: By Disease Type
      • 6.1.1 Global Preventive Vaccine Market share, By Disease Type, 2024 and 2034
    • 6.2 Hepatitis
      • 6.2.1 Global Preventive Vaccine Market by Hepatitis, 2025 - 2034 (USD Billion )
    • 6.3 Poliovirus
      • 6.3.1 Global Preventive Vaccine Market by Poliovirus, 2025 - 2034 (USD Billion )
    • 6.4 Pneumococcal
      • 6.4.1 Global Preventive Vaccine Market by Pneumococcal, 2025 - 2034 (USD Billion )
    • 6.5 Rubella
      • 6.5.1 Global Preventive Vaccine Market by Rubella, 2025 - 2034 (USD Billion )
    • 6.6 Measles
      • 6.6.1 Global Preventive Vaccine Market by Measles, 2025 - 2034 (USD Billion )
    • 6.7 Others
      • 6.7.1 Global Preventive Vaccine Market by Others, 2025 - 2034 (USD Billion )
  • Chapter 7. Preventive Vaccine Market - Regional Analysis
    • 7.1 Global Preventive Vaccine Market Regional Overview
    • 7.2 Global Preventive Vaccine Market Share, by Region, 2024 & 2034 (USD Billion )
    • 7.3. North America
      • 7.3.1 North America Preventive Vaccine Market, 2025 - 2034 (USD Billion )
        • 7.3.1.1 North America Preventive Vaccine Market, by Country, 2025 - 2034 (USD Billion )
    • 7.4 North America Preventive Vaccine Market, by Vaccine Type, 2025 - 2034
      • 7.4.1 North America Preventive Vaccine Market, by Vaccine Type, 2025 - 2034 (USD Billion )
    • 7.5 North America Preventive Vaccine Market, by Disease Type, 2025 - 2034
      • 7.5.1 North America Preventive Vaccine Market, by Disease Type, 2025 - 2034 (USD Billion )
    • 7.4. Europe
      • 7.4.2 Europe Preventive Vaccine Market, 2025 - 2034 (USD Billion )
        • 7.4.2.1 Europe Preventive Vaccine Market, by Country, 2025 - 2034 (USD Billion )
    • 7.4 Europe Preventive Vaccine Market, by Vaccine Type, 2025 - 2034
      • 7.4.1 Europe Preventive Vaccine Market, by Vaccine Type, 2025 - 2034 (USD Billion )
    • 7.5 Europe Preventive Vaccine Market, by Disease Type, 2025 - 2034
      • 7.5.1 Europe Preventive Vaccine Market, by Disease Type, 2025 - 2034 (USD Billion )
    • 7.5. Asia Pacific
      • 7.5.3 Asia Pacific Preventive Vaccine Market, 2025 - 2034 (USD Billion )
        • 7.5.3.1 Asia Pacific Preventive Vaccine Market, by Country, 2025 - 2034 (USD Billion )
    • 7.4 Asia Pacific Preventive Vaccine Market, by Vaccine Type, 2025 - 2034
      • 7.4.1 Asia Pacific Preventive Vaccine Market, by Vaccine Type, 2025 - 2034 (USD Billion )
    • 7.5 Asia Pacific Preventive Vaccine Market, by Disease Type, 2025 - 2034
      • 7.5.1 Asia Pacific Preventive Vaccine Market, by Disease Type, 2025 - 2034 (USD Billion )
    • 7.6. Latin America
      • 7.6.4 Latin America Preventive Vaccine Market, 2025 - 2034 (USD Billion )
        • 7.6.4.1 Latin America Preventive Vaccine Market, by Country, 2025 - 2034 (USD Billion )
    • 7.4 Latin America Preventive Vaccine Market, by Vaccine Type, 2025 - 2034
      • 7.4.1 Latin America Preventive Vaccine Market, by Vaccine Type, 2025 - 2034 (USD Billion )
    • 7.5 Latin America Preventive Vaccine Market, by Disease Type, 2025 - 2034
      • 7.5.1 Latin America Preventive Vaccine Market, by Disease Type, 2025 - 2034 (USD Billion )
    • 7.7. The Middle-East and Africa
      • 7.7.5 The Middle-East and Africa Preventive Vaccine Market, 2025 - 2034 (USD Billion )
        • 7.7.5.1 The Middle-East and Africa Preventive Vaccine Market, by Country, 2025 - 2034 (USD Billion )
    • 7.4 The Middle-East and Africa Preventive Vaccine Market, by Vaccine Type, 2025 - 2034
      • 7.4.1 The Middle-East and Africa Preventive Vaccine Market, by Vaccine Type, 2025 - 2034 (USD Billion )
    • 7.5 The Middle-East and Africa Preventive Vaccine Market, by Disease Type, 2025 - 2034
      • 7.5.1 The Middle-East and Africa Preventive Vaccine Market, by Disease Type, 2025 - 2034 (USD Billion )
  • Chapter 8. Company Profiles
    • 8.1 Johnson & Johnson, GlaxoSmithKline (GSK), Pfizer, Bharat Biotech, CSL (Seqirus), AstraZeneca, Sinopharm, Moderna, Novavax, Valneva, Merck, Serum Institute of India, Takeda, Sanofi, Sinovac, and others.
      • 8.1.1 Overview
      • 8.1.2 Financials
      • 8.1.3 Product Portfolio
      • 8.1.4 Business Strategy
      • 8.1.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Preventive Vaccine Market, 2025 - 2034 (USD Billion )
  • 4. Porter’s Five Forces Analysis
  • 5. Global Preventive Vaccine Market attractiveness, By Vaccine Type
  • 6. Global Preventive Vaccine Market attractiveness, By Disease Type
  • 7. Global Preventive Vaccine Market share by Vaccine Type, 2025 and 2034 (USD Billion )
  • 8. Global Preventive Vaccine Market by Inactivated Vaccines, 2025 - 2034 (USD Billion )
  • 9. Global Preventive Vaccine Market by Live/Attenuated Vaccines, 2025 - 2034 (USD Billion )
  • 10. Global Preventive Vaccine Market by Toxoid Vaccines, 2025 - 2034 (USD Billion )
  • 11. Global Preventive Vaccine Market by Subunit Vaccines, 2025 - 2034 (USD Billion )
  • 12. Global Preventive Vaccine Market by Others, 2025 - 2034 (USD Billion )
  • 13. Global Preventive Vaccine Market share by Disease Type, 2025 and 2034 (USD Billion )
  • 14. Global Preventive Vaccine Market by Hepatitis, 2025 - 2034 (USD Billion )
  • 15. Global Preventive Vaccine Market by Poliovirus, 2025 - 2034 (USD Billion )
  • 16. Global Preventive Vaccine Market by Pneumococcal, 2025 - 2034 (USD Billion )
  • 17. Global Preventive Vaccine Market by Rubella, 2025 - 2034 (USD Billion )
  • 18. Global Preventive Vaccine Market by Measles, 2025 - 2034 (USD Billion )
  • 19. Global Preventive Vaccine Market by Others, 2025 - 2034 (USD Billion )
  • 20. Global Preventive Vaccine Market share, by Region, 2025 and 2034
  • 21. North America Preventive Vaccine Market, 2025 - 2034 (USD Billion )
  • 22. Europe Preventive Vaccine Market, 2025 - 2034 (USD Billion )
  • 23. Asia Pacific Preventive Vaccine Market, 2025 - 2034 (USD Billion )
  • 24. Latin America Preventive Vaccine Market, 2025 - 2034 (USD Billion )
  • 25. The Middle-East and Africa Preventive Vaccine Market, 2025 - 2034 (USD Billion )

Table Of Tables

  • 1. Global Preventive Vaccine Market: Snapshot
  • 2. Drivers of the Preventive Vaccine Market: impact analysis
  • 3. North America Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 4. North America Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 5. U.S. Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 6. U.S. Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 7. Canada Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 8. Canada Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 9. Europe Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 10. Europe Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 11. Germany Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 12. Germany Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 13. France Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 14. France Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 15. U.K. Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 16. U.K. Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 17. Italy Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 18. Italy Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 19. Spain Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 20. Spain Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 21. Rest of Europe Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 22. Rest of Europe Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 23. Asia Pacific Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 24. Asia Pacific Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 25. China Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 26. China Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 27. Japan Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 28. Japan Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 29. India Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 30. India Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 31. South Korea Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 32. South Korea Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 33. South-East Asia Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 34. South-East Asia Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 35. Rest of Asia Pacific Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 36. Rest of Asia Pacific Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 37. Latin America Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 38. Latin America Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 39. Brazil Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 40. Brazil Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 41. Mexico Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 42. Mexico Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 43. Rest of Latin America Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 44. Rest of Latin America Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 45. The Middle-East and Africa Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 46. The Middle-East and Africa Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 47. GCC Countries Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 48. GCC Countries Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 49. South Africa Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 50. South Africa Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 51. Rest of Middle-East Africa Preventive Vaccine Market revenue, By Vaccine Type, 2025 - 2034 (USD Billion )
  • 52. Rest of Middle-East Africa Preventive Vaccine Market revenue, By Disease Type, 2025 - 2034 (USD Billion )

Methodology

FrequentlyAsked Questions

Preventive vaccines are designed to prevent the user from getting infected with a specific infectious disease.
The global preventive vaccine market is expected to benefit from the rising public health awareness worldwide.
According to study, the global preventive vaccine market size was worth around USD 59.83 billion in 2024 and is predicted to grow to around USD 136.46 billion by 2034.
The CAGR value of the preventive vaccine market is expected to be around 9.12% during 2025-2034.
The global preventive vaccine industry is likely to be challenged by the complexity of regulatory requirements concerning the R&D of new vaccines.
Entry into emerging markets and advancements in delivery mechanisms are market trends evolving in the preventive vaccine market.
The poliovirus segment is expected to dominate the preventive vaccine market by 2034.
The global preventive vaccine market will be led by North America during the forecast period.
The global preventive vaccine market is led by players like Johnson & Johnson, GlaxoSmithKline (GSK), Pfizer, Bharat Biotech, CSL (Seqirus), AstraZeneca, Sinopharm, Moderna, Novavax, Valneva, Merck, Serum Institute of India, Takeda, Sanofi, and Sinovac.
The report explores crucial aspects of the preventive vaccine market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
  • zion payment modes

List of Contents

Preventive VaccineIndustry Perspective:Key Insights:OverviewMarket DynamicsReport ScopeSegmentationRegional AnalysisCompetitive AnalysisKey Market TrendsThe global preventive vaccine market is segmented as follows:

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed